Our business areas Bioprinting, Biosciences and
Bioautomation is comprised of several subsidiaries that work decentralized with focused management groups. Natural collaborations within product development, marketing and sales lead to positive synergies.
State-of-the-art systems, products, solutions and services that combine user-friendliness, accessibility and cutting-edge capabilities to enable the proliferation of 3D cell culture with any cell line, in any geometry, using any biomaterial.
Facilitate faster and smarter workflows in multiomics, biopharma cell line development (CLD), combinatorial screenings and next-generation sequencing.
Accelerating the development and manufacturing of innovative, reliable, cost-efficient diagnostic and bioanalysis test platforms for the sake of patients, consumers, public health and the environment.